Related Experiment Video

Updated: Jul 10, 2026

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
06:23

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice

Published on: September 22, 2020

Fatal familial insomnia and agrypnia excitata

Elio Lugaresi1, Federica Provini

  • 1Department of Neurological Sciences, University of Bologna, Italy.

Reviews in Neurological Diseases
|October 19, 2007
PubMed

Insights

Fatal familial insomnia (FFI) is a rare, inherited prion disease. This review details its identification and the agrypnia excitata syndrome, linked to thalamolimbic circuit dysfunction affecting sleep and autonomic control.

Area of Science:

  • Neuroscience
  • Genetics
  • Sleep Medicine

Background:

  • Fatal familial insomnia (FFI) is a rare, inherited prion disease.
  • FFI shares symptoms with Morvan's chorea and delirium tremens, including sleep disturbances and overactivation.

Purpose of the Study:

  • To review the identification of FFI and the characterization of the agrypnia excitata syndrome.
  • To highlight the role of thalamolimbic circuits in sleep-wake regulation and autonomic control.

Main Methods:

  • Literature review of pioneering research on FFI.
  • Analysis of clinical and pathological findings in FFI and related disorders.

Main Results:

  • Identification of FFI as a distinct hereditary prion disease.
  • Definition of agrypnia excitata syndrome, characterized by insomnia and autonomic/motor overactivation.
  • Pinpointing dysfunction in thalamolimbic circuits as the cause of agrypnia excitata.

Conclusions:

  • The limbic thalamus plays a critical role in the central autonomic network.
  • Dysfunction in thalamolimbic circuits disrupts sleep-wakefulness and autonomic regulation.
  • Understanding these circuits is key to comprehending FFI and related disorders.

More Related Videos

Polygraphic Recording Procedure for Measuring Sleep in Mice08:45

Polygraphic Recording Procedure for Measuring Sleep in Mice

Published on: January 25, 2016

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster05:59

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster

Published on: October 20, 2023

Related Concept Videos

Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Narcolepsy01:07

Narcolepsy

Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Insomnia01:27

Insomnia

Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...